RIFIZOSTREP – A NEW COMBINED PREPARATE AGAINST TUBERCULOSIS MICOBACTERS
G. H. Mamadullaev, Б Элмуродов, О. А. Джураев, O. K. Dzhurakulov, U. M. Fayziev
Epizootology Immunobiology Pharmacology Sanitation · 2022-12
Abstract
The article presents the results of in vivo laboratory tests of a new «Rifizostrep» anti-TB drug. «Rifizostrep» in the organism of experimentally infected 27 guinea pigs. It is obtained that the preparation «Rifizostrep» in organism of guinea pigs at 10 мg/кg dose has sufficient antimicrobial activity against mycobacterium a tuberculosis of type M. bo-vis and M. tuberculosis
MeSH terms
- Tuberculosis
- Mycobacterium tuberculosis
- Antimicrobial
- Microbiology
- Organism
- In vivo
- Biology
- Virology
- Medicine